speb/financial-data huggingface dataset:
HBH.DE income_statement (quarterly, 2026-05-31) — Net Income Common Stockholders: 99800000.00
HBH.DE income_statement (quarterly, 2026-05-31) — Net Income Continuous Operations: 104200000.00
HBH.DE income_statement (quarterly, 2026-05-31) — Net Income From Continuing And Discontinued Operation: 99800000.00
HBH.DE income_statement (quarterly, 2026-05-31) — Net Income From Continuing Operation Net Minority Interest: 99800000.00
HBH.DE cash_flow (quarterly, 2026-05-31) — Net Income From Continuing Operations: 104200000.00
HBH.DE income_statement (quarterly, 2026-05-31) — Net Income Including Noncontrolling Interests: 104200000.00
HBH.DE cash_flow (quarterly, 2026-05-31) — Net Intangibles Purchase And Sale: -7600000.00
HBH.DE income_statement (quarterly, 2026-05-31) — Net Interest Income: -20200000.00
HBH.DE cash_flow (quarterly, 2026-05-31) — Net Investment Purchase And Sale: -600000.00
HBH.DE cash_flow (quarterly, 2026-05-31) — Net Issuance Payments Of Debt: 390300000.00
HBH.DE cash_flow (quarterly, 2026-05-31) — Net Long Term Debt Issuance: 390300000.00
HBH.DE income_statement (quarterly, 2026-05-31) — Net Non Operating Interest Income Expense: -20200000.00
HBH.DE cash_flow (quarterly, 2026-05-31) — Net Other Financing Charges: -500000.00
HBH.DE cash_flow (quarterly, 2026-05-31) — Net Other Investing Changes: 600000.00
HBH.DE balance_sheet (quarterly, 2026-05-31) — Net PPE: 2850400000.00
HBH.DE cash_flow (quarterly, 2026-05-31) — Net PPE Purchase And Sale: -37400000.00
HBH.DE balance_sheet (quarterly, 2026-05-31) — Net Tangible Assets: 2071300000.00
HBH.DE balance_sheet (quarterly, 2026-05-31) — Non Current Deferred Taxes Assets: 49000000.00
HBH.DE balance_sheet (quarterly, 2026-05-31) — Non Current Deferred Taxes Liabilities: 24600000.00
HBH.DE balance_sheet (quarterly, 2026-05-31) — Non Current Pension And Other Postretirement Benefit Plans: 7000000.00
HBH.DE income_statement (quarterly, 2026-05-31) — Normalized EBITDA: 218400000.00
HBH.DE income_statement (quarterly, 2026-05-31) — Normalized Income: 101207107.32
HBH.DE cash_flow (quarterly, 2026-05-31) — Operating Cash Flow: 198000000.00
HBH.DE income_statement (quarterly, 2026-05-31) — Operating Income: 162800000.00
HBH.DE income_statement (quarterly, 2026-05-31) — Operating Revenue: 2002400000.00
HBH.DE balance_sheet (quarterly, 2026-05-31) — Ordinary Shares Number: 15999810.00
HBH.DE cash_flow (quarterly, 2026-05-31) — Other Cash Adjustment Outside Changein Cash: 1000000.00
HBH.DE balance_sheet (quarterly, 2026-05-31) — Other Current Assets: 121300000.00
HBH.DE balance_sheet (quarterly, 2026-05-31) — Other Current Liabilities: 185500000.00
HBH.DE cash_flow (quarterly, 2026-05-31) — Other Non Cash Items: 8600000.00
HBH.DE balance_sheet (quarterly, 2026-05-31) — Other Non Current Assets: 10700000.00
HBH.DE balance_sheet (quarterly, 2026-05-31) — Other Non Current Liabilities: 48000000.00
HBH.DE income_statement (quarterly, 2026-05-31) — Other Operating Expenses: -2500000.00
HBH.DE balance_sheet (quarterly, 2026-05-31) — Other Properties: 2850400000.00
HBH.DE balance_sheet (quarterly, 2026-05-31) — Other Receivables: 2200000.00
HBH.DE balance_sheet (quarterly, 2026-05-31) — Other Short Term Investments: 200000.00
HBH.DE income_statement (quarterly, 2026-05-31) — Other Special Charges: 1900000.00
HBH.DE income_statement (quarterly, 2026-05-31) — Otherunder Preferred Stock Dividend: 0.00
HBH.DE balance_sheet (quarterly, 2026-05-31) — Payables: 529000000.00
HBH.DE income_statement (quarterly, 2026-05-31) — Pretax Income: 140700000.00
HBH.DE cash_flow (quarterly, 2026-05-31) — Purchase Of Business: -10900000.00
HBH.DE cash_flow (quarterly, 2026-05-31) — Purchase Of Intangibles: -7600000.00
HBH.DE cash_flow (quarterly, 2026-05-31) — Purchase Of Investment: -600000.00
HBH.DE cash_flow (quarterly, 2026-05-31) — Purchase Of PPE: -37400000.00
HBH.DE income_statement (quarterly, 2026-05-31) — Reconciled Cost Of Revenue: 1302500000.00
HBH.DE income_statement (quarterly, 2026-05-31) — Reconciled Depreciation: 58200000.00
HBH.DE cash_flow (quarterly, 2026-05-31) — Repayment Of Debt: -4700000.00
HBH.DE income_statement (quarterly, 2026-05-31) — Selling And Marketing Expense: 451800000.00
HBH.DE income_statement (quarterly, 2026-05-31) — Selling General And Administration: 539600000.00
HBH.DE balance_sheet (quarterly, 2026-05-31) — Share Issued: 15999810.00
HBH.DE income_statement (quarterly, 2026-05-31) — Special Income Charges: -1900000.00
HBH.DE balance_sheet (quarterly, 2026-05-31) — Stockholders Equity: 2163600000.00
HBH.DE balance_sheet (quarterly, 2026-05-31) — Tangible Book Value: 2071300000.00
HBH.DE income_statement (quarterly, 2026-05-31) — Tax Effect Of Unusual Items: -492892.68
HBH.DE income_statement (quarterly, 2026-05-31) — Tax Provision: 36500000.00
HBH.DE income_statement (quarterly, 2026-05-31) — Tax Rate For Calcs: 0.26
HBH.DE balance_sheet (quarterly, 2026-05-31) — Taxes Receivable: 21500000.00
HBH.DE balance_sheet (quarterly, 2026-05-31) — Total Assets: 5322800000.00
HBH.DE balance_sheet (quarterly, 2026-05-31) — Total Capitalization: 2894500000.00
HBH.DE balance_sheet (quarterly, 2026-05-31) — Total Debt: 2039200000.00
HBH.DE balance_sheet (quarterly, 2026-05-31) — Total Equity Gross Minority Interest: 2250300000.00
HBH.DE income_statement (quarterly, 2026-05-31) — Total Expenses: 1839600000.00
HBH.DE balance_sheet (quarterly, 2026-05-31) — Total Liabilities Net Minority Interest: 3072500000.00
HBH.DE balance_sheet (quarterly, 2026-05-31) — Total Non Current Assets: 3024000000.00
HBH.DE balance_sheet (quarterly, 2026-05-31) — Total Non Current Liabilities Net Minority Interest: 1712100000.00
HBH.DE income_statement (quarterly, 2026-05-31) — Total Other Finance Cost: 4600000.00
HBH.DE balance_sheet (quarterly, 2026-05-31) — Total Tax Payable: 40900000.00
HBH.DE income_statement (quarterly, 2026-05-31) — Total Unusual Items: -1900000.00
HBH.DE income_statement (quarterly, 2026-05-31) — Total Unusual Items Excluding Goodwill: -1900000.00
HBH.DE balance_sheet (quarterly, 2026-05-31) — Working Capital: 938400000.00
HBIO cash_flow (annual, 2021-12-31) — Change In Other Current Liabilities: -2555000.00
HBIO balance_sheet (annual, 2021-12-31) — Current Debt: 3235000.00
HBIO balance_sheet (annual, 2021-12-31) — Current Provisions: 240000.00
HBIO cash_flow (annual, 2021-12-31) — Income Tax Paid Supplemental Data: 577000.00
HBIO balance_sheet (annual, 2021-12-31) — Income Tax Payable: 224000.00
HBIO balance_sheet (annual, 2021-12-31) — Long Term Debt: 45095000.00
HBIO cash_flow (annual, 2021-12-31) — Net Intangibles Purchase And Sale: -150000.00
HBIO cash_flow (annual, 2021-12-31) — Net Short Term Debt Issuance: 2050000.00
HBIO balance_sheet (annual, 2021-12-31) — Other Current Borrowings: 3235000.00
HBIO cash_flow (annual, 2021-12-31) — Purchase Of Intangibles: -150000.00
HBIO cash_flow (annual, 2021-12-31) — Short Term Debt Issuance: 4250000.00
HBIO cash_flow (annual, 2021-12-31) — Short Term Debt Payments: -2200000.00
HBIO balance_sheet (annual, 2021-12-31) — Total Tax Payable: 224000.00
HBIO balance_sheet (annual, 2021-12-31) — Treasury Stock: 0.00
HBIO income_statement (annual, 2022-12-31) — +Operating Expense: 67985000.00
HBIO income_statement (annual, 2022-12-31) — +Total Revenue: 113335000.00
HBIO balance_sheet (annual, 2022-12-31) — Accounts Payable: 6447000.00
HBIO balance_sheet (annual, 2022-12-31) — Accounts Receivable: 16705000.00
HBIO balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -14846000.00
HBIO balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 229008000.00
HBIO balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -191000.00
HBIO income_statement (annual, 2022-12-31) — Amortization: 6122000.00
HBIO cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 6122000.00
HBIO cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 6122000.00
HBIO income_statement (annual, 2022-12-31) — Amortization Of Intangibles Income Statement: 6122000.00
HBIO income_statement (annual, 2022-12-31) — Basic Average Shares: 4141300.00
HBIO income_statement (annual, 2022-12-31) — Basic EPS: -2.30
HBIO cash_flow (annual, 2022-12-31) — Beginning Cash Position: 7821000.00
HBIO cash_flow (annual, 2022-12-31) — Capital Expenditure: -1590000.00
HBIO cash_flow (annual, 2022-12-31) — Capital Expenditure Reported: 0.00
HBIO balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 7417000.00
HBIO balance_sheet (annual, 2022-12-31) — Capital Stock: 454000.00
HBIO balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 4508000.00
HBIO balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 4508000.00
HBIO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -2837000.00
HBIO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -1590000.00
HBIO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 1152000.00
HBIO cash_flow (annual, 2022-12-31) — Change In Account Payable: -1399000.00
HBIO cash_flow (annual, 2022-12-31) — Change In Inventory: 252000.00
HBIO cash_flow (annual, 2022-12-31) — Change In Other Current Assets: 474000.00
HBIO cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -495000.00
HBIO cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -896000.00
HBIO cash_flow (annual, 2022-12-31) — Change In Payable: -1399000.00
HBIO cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: -1399000.00
HBIO cash_flow (annual, 2022-12-31) — Change In Receivables: 4780000.00
HBIO cash_flow (annual, 2022-12-31) — Change In Working Capital: 2716000.00
HBIO cash_flow (annual, 2022-12-31) — Changes In Account Receivables: 4780000.00
HBIO cash_flow (annual, 2022-12-31) — Changes In Cash: -3275000.00
HBIO balance_sheet (annual, 2022-12-31) — Common Stock: 454000.00
HBIO balance_sheet (annual, 2022-12-31) — Common Stock Equity: 72220000.00
HBIO income_statement (annual, 2022-12-31) — Cost Of Revenue: 52516000.00
HBIO balance_sheet (annual, 2022-12-31) — Current Assets: 51124000.00
HBIO balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 2135000.00
HBIO balance_sheet (annual, 2022-12-31) — Current Debt: 3811000.00
HBIO balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 5946000.00
HBIO balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 3370000.00
HBIO balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 3370000.00
HBIO balance_sheet (annual, 2022-12-31) — Current Liabilities: 23249000.00
HBIO balance_sheet (annual, 2022-12-31) — Current Provisions: 268000.00
HBIO cash_flow (annual, 2022-12-31) — Deferred Income Tax: -414000.00
HBIO cash_flow (annual, 2022-12-31) — Deferred Tax: -414000.00
HBIO cash_flow (annual, 2022-12-31) — Depreciation: 1453000.00
HBIO cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 7575000.00
HBIO income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 6122000.00
HBIO cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 7575000.00
HBIO income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 6122000.00
HBIO income_statement (annual, 2022-12-31) — Diluted Average Shares: 4141300.00
HBIO income_statement (annual, 2022-12-31) — Diluted EPS: -2.30
HBIO income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -9516000.00
HBIO income_statement (annual, 2022-12-31) — EBIT: -6631000.00
HBIO income_statement (annual, 2022-12-31) — EBITDA: 944000.00
HBIO cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -38000.00
HBIO cash_flow (annual, 2022-12-31) — End Cash Position: 4508000.00
HBIO cash_flow (annual, 2022-12-31) — Financing Cash Flow: -2837000.00
HBIO balance_sheet (annual, 2022-12-31) — Finished Goods: 5223000.00
HBIO cash_flow (annual, 2022-12-31) — Free Cash Flow: -438000.00
HBIO cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of Business: 0.00
HBIO balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -15052000.00
HBIO income_statement (annual, 2022-12-31) — General And Administrative Expense: 24493000.00
HBIO balance_sheet (annual, 2022-12-31) — Goodwill: 56260000.00
HBIO balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 77274000.00
HBIO balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 16896000.00
HBIO balance_sheet (annual, 2022-12-31) — Gross PPE: 24028000.00
HBIO income_statement (annual, 2022-12-31) — Gross Profit: 60819000.00
HBIO cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 534000.00
HBIO balance_sheet (annual, 2022-12-31) — Income Tax Payable: 0.00
HBIO income_statement (annual, 2022-12-31) — Interest Expense: 2548000.00
HBIO income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 2548000.00
HBIO cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 2314000.00
HBIO balance_sheet (annual, 2022-12-31) — Inventory: 26439000.00
HBIO balance_sheet (annual, 2022-12-31) — Invested Capital: 119044000.00
HBIO cash_flow (annual, 2022-12-31) — Investing Cash Flow: -1590000.00
HBIO cash_flow (annual, 2022-12-31) — Issuance Of Debt: 7800000.00
HBIO balance_sheet (annual, 2022-12-31) — Leases: 2507000.00
HBIO balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 5282000.00
HBIO balance_sheet (annual, 2022-12-31) — Long Term Debt: 43013000.00
HBIO balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 48295000.00
HBIO cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 7800000.00
HBIO cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -9586000.00
HBIO balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 15705000.00
HBIO cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 0.00
HBIO balance_sheet (annual, 2022-12-31) — Net Debt: 42316000.00
HBIO income_statement (annual, 2022-12-31) — Net Income: -9516000.00
HBIO income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -9516000.00
HBIO income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -9516000.00
HBIO income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -9516000.00
HBIO income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -9516000.00
HBIO cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -9516000.00
HBIO income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -9516000.00
HBIO cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: 0.00
HBIO income_statement (annual, 2022-12-31) — Net Interest Income: -2548000.00
HBIO cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -1786000.00
HBIO cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -1786000.00
HBIO income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -2548000.00
HBIO cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -1628000.00
HBIO balance_sheet (annual, 2022-12-31) — Net PPE: 9182000.00
HBIO cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -1590000.00
HBIO cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 1400000.00
HBIO balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -5054000.00
HBIO balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 590000.00
HBIO balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 590000.00
HBIO income_statement (annual, 2022-12-31) — Normalized EBITDA: 711000.00
HBIO income_statement (annual, 2022-12-31) — Normalized Income: -9700070.00
HBIO cash_flow (annual, 2022-12-31) — Operating Cash Flow: 1152000.00
HBIO income_statement (annual, 2022-12-31) — Operating Income: -7166000.00
HBIO income_statement (annual, 2022-12-31) — Operating Revenue: 113335000.00
HBIO balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 4208170.00
HBIO balance_sheet (annual, 2022-12-31) — Other Current Assets: 3472000.00
HBIO balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 3811000.00
HBIO balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 4010000.00
HBIO balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -15052000.00
HBIO income_statement (annual, 2022-12-31) — Other Gand A: 24493000.00
HBIO income_statement (annual, 2022-12-31) — Other Income Expense: 535000.00
HBIO balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 21014000.00
HBIO cash_flow (annual, 2022-12-31) — Other Non Cash Items: -3620000.00
HBIO balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 7780000.00
HBIO balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 1006000.00
HBIO income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 302000.00
HBIO balance_sheet (annual, 2022-12-31) — Other Properties: 5816000.00
HBIO income_statement (annual, 2022-12-31) — Other Special Charges: -233000.00
HBIO balance_sheet (annual, 2022-12-31) — Payables: 6447000.00
HBIO balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 6447000.00
HBIO balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 3476000.00
HBIO balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
HBIO income_statement (annual, 2022-12-31) — Pretax Income: -9179000.00
HBIO cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 577000.00
HBIO balance_sheet (annual, 2022-12-31) — Properties: 0.00
HBIO cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: 0.00
HBIO cash_flow (annual, 2022-12-31) — Purchase Of PPE: -1590000.00
HBIO balance_sheet (annual, 2022-12-31) — Raw Materials: 17440000.00
HBIO balance_sheet (annual, 2022-12-31) — Receivables: 16705000.00
HBIO income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 51063000.00
HBIO income_statement (annual, 2022-12-31) — Reconciled Depreciation: 7575000.00
HBIO cash_flow (annual, 2022-12-31) — Repayment Of Debt: -9586000.00
HBIO income_statement (annual, 2022-12-31) — Research And Development: 12329000.00
HBIO balance_sheet (annual, 2022-12-31) — Retained Earnings: -142190000.00
HBIO cash_flow (annual, 2022-12-31) — Sale Of Business: 0.00
HBIO income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 25041000.00
HBIO income_statement (annual, 2022-12-31) — Selling General And Administration: 49534000.00
HBIO balance_sheet (annual, 2022-12-31) — Share Issued: 4208170.00
HBIO cash_flow (annual, 2022-12-31) — Short Term Debt Issuance: 7800000.00
HBIO cash_flow (annual, 2022-12-31) — Short Term Debt Payments: -6400000.00
HBIO income_statement (annual, 2022-12-31) — Special Income Charges: 233000.00
HBIO cash_flow (annual, 2022-12-31) — Stock Based Compensation: 4411000.00
HBIO balance_sheet (annual, 2022-12-31) — Stockholders Equity: 72220000.00
HBIO balance_sheet (annual, 2022-12-31) — Tangible Book Value: -5054000.00
HBIO income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 48930.00
HBIO income_statement (annual, 2022-12-31) — Tax Provision: 337000.00
HBIO income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.21
HBIO balance_sheet (annual, 2022-12-31) — Total Assets: 145360000.00
HBIO balance_sheet (annual, 2022-12-31) — Total Capitalization: 115233000.00
HBIO balance_sheet (annual, 2022-12-31) — Total Debt: 54241000.00
HBIO balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 72220000.00
HBIO income_statement (annual, 2022-12-31) — Total Expenses: 120501000.00
HBIO balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 73140000.00
HBIO balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 94236000.00
HBIO balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 49891000.00
HBIO income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -6933000.00
HBIO balance_sheet (annual, 2022-12-31) — Total Tax Payable: 0.00
HBIO income_statement (annual, 2022-12-31) — Total Unusual Items: 233000.00
HBIO income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 233000.00
HBIO balance_sheet (annual, 2022-12-31) — Treasury Stock: 0.00
HBIO cash_flow (annual, 2022-12-31) — Unrealized Gain Loss On Investment Securities: 0.00
HBIO balance_sheet (annual, 2022-12-31) — Work In Process: 3776000.00
HBIO balance_sheet (annual, 2022-12-31) — Working Capital: 27875000.00
HBIO income_statement (annual, 2023-12-31) — +Operating Expense: 64177000.00
HBIO income_statement (annual, 2023-12-31) — +Total Revenue: 112250000.00
HBIO balance_sheet (annual, 2023-12-31) — Accounts Payable: 5554000.00
HBIO balance_sheet (annual, 2023-12-31) — Accounts Receivable: 16099000.00
HBIO balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -14385000.00
HBIO balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 232435000.00
HBIO balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -160000.00
HBIO income_statement (annual, 2023-12-31) — Amortization: 5525000.00
HBIO cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 5525000.00
HBIO cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: 5525000.00
HBIO income_statement (annual, 2023-12-31) — Amortization Of Intangibles Income Statement: 5525000.00
HBIO income_statement (annual, 2023-12-31) — Basic Average Shares: 4242000.00
HBIO income_statement (annual, 2023-12-31) — Basic EPS: -0.80
HBIO cash_flow (annual, 2023-12-31) — Beginning Cash Position: 4508000.00
HBIO cash_flow (annual, 2023-12-31) — Capital Expenditure: -2311000.00
HBIO cash_flow (annual, 2023-12-31) — Capital Expenditure Reported: -523000.00
HBIO balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 6210000.00
HBIO balance_sheet (annual, 2023-12-31) — Capital Stock: 434000.00
HBIO balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 4283000.00
HBIO balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 4283000.00
HBIO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -12134000.00
HBIO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -1799000.00
HBIO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 14028000.00
HBIO cash_flow (annual, 2023-12-31) — Change In Account Payable: -523000.00
HBIO cash_flow (annual, 2023-12-31) — Change In Inventory: 1524000.00
HBIO cash_flow (annual, 2023-12-31) — Change In Other Current Assets: 1651000.00
HBIO cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -1078000.00
HBIO cash_flow (annual, 2023-12-31) — Change In Other Working Capital: 1138000.00
HBIO cash_flow (annual, 2023-12-31) — Change In Payable: -523000.00
HBIO cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -523000.00
HBIO cash_flow (annual, 2023-12-31) — Change In Receivables: 810000.00
HBIO cash_flow (annual, 2023-12-31) — Change In Working Capital: 4600000.00
HBIO cash_flow (annual, 2023-12-31) — Changes In Account Receivables: 810000.00
HBIO cash_flow (annual, 2023-12-31) — Changes In Cash: 95000.00
HBIO balance_sheet (annual, 2023-12-31) — Common Stock: 434000.00
HBIO balance_sheet (annual, 2023-12-31) — Common Stock Equity: 73074000.00
HBIO income_statement (annual, 2023-12-31) — Cost Of Revenue: 46179000.00
HBIO balance_sheet (annual, 2023-12-31) — Current Assets: 49038000.00
HBIO balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 1416000.00
HBIO balance_sheet (annual, 2023-12-31) — Current Debt: 5859000.00
HBIO balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 7275000.00
HBIO balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 4508000.00
HBIO balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 4508000.00
HBIO balance_sheet (annual, 2023-12-31) — Current Liabilities: 26542000.00
HBIO cash_flow (annual, 2023-12-31) — Deferred Income Tax: 336000.00
HBIO cash_flow (annual, 2023-12-31) — Deferred Tax: 336000.00
HBIO cash_flow (annual, 2023-12-31) — Depreciation: 1473000.00
HBIO cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 6998000.00
HBIO income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 5525000.00
HBIO cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 6998000.00
HBIO income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 5525000.00
HBIO income_statement (annual, 2023-12-31) — Diluted Average Shares: 4242000.00
HBIO income_statement (annual, 2023-12-31) — Diluted EPS: -0.80
HBIO income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -3415000.00
HBIO income_statement (annual, 2023-12-31) — EBIT: 1035000.00
HBIO income_statement (annual, 2023-12-31) — EBITDA: 8033000.00
HBIO cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -320000.00
HBIO cash_flow (annual, 2023-12-31) — End Cash Position: 4283000.00
HBIO cash_flow (annual, 2023-12-31) — Financing Cash Flow: -12134000.00
HBIO balance_sheet (annual, 2023-12-31) — Finished Goods: 5120000.00
HBIO cash_flow (annual, 2023-12-31) — Free Cash Flow: 11717000.00
HBIO cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 632000.00
HBIO cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of Business: -403000.00
HBIO income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -632000.00
HBIO balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -14190000.00
HBIO income_statement (annual, 2023-12-31) — General And Administrative Expense: 22757000.00
HBIO balance_sheet (annual, 2023-12-31) — Goodwill: 57065000.00
HBIO balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 73101000.00
HBIO balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 16259000.00
HBIO balance_sheet (annual, 2023-12-31) — Gross PPE: 23139000.00
HBIO income_statement (annual, 2023-12-31) — Gross Profit: 66071000.00
HBIO cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 207000.00
HBIO income_statement (annual, 2023-12-31) — Interest Expense: 3591000.00
HBIO income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 3591000.00
HBIO cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 3795000.00
HBIO balance_sheet (annual, 2023-12-31) — Inventory: 24716000.00
HBIO balance_sheet (annual, 2023-12-31) — Invested Capital: 109637000.00
HBIO cash_flow (annual, 2023-12-31) — Investing Cash Flow: -1799000.00
HBIO cash_flow (annual, 2023-12-31) — Issuance Of Debt: 4500000.00
HBIO balance_sheet (annual, 2023-12-31) — Leases: 2417000.00
HBIO balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 4794000.00
HBIO balance_sheet (annual, 2023-12-31) — Long Term Debt: 30704000.00
HBIO balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 35498000.00
HBIO cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 4500000.00
HBIO cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -15041000.00
HBIO balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 15949000.00
HBIO cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 512000.00
HBIO balance_sheet (annual, 2023-12-31) — Net Debt: 32280000.00
HBIO income_statement (annual, 2023-12-31) — Net Income: -3415000.00
HBIO income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -3415000.00
HBIO income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -3415000.00
HBIO income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -3415000.00
HBIO income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -3415000.00
HBIO cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -3415000.00
HBIO income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -3415000.00
HBIO income_statement (annual, 2023-12-31) — Net Interest Income: -3591000.00
HBIO cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 0.00
HBIO cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -10541000.00
HBIO cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -10541000.00
HBIO income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -3591000.00
HBIO cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -2523000.00
HBIO balance_sheet (annual, 2023-12-31) — Net PPE: 8754000.00
HBIO cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -1788000.00
HBIO balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -27000.00
HBIO balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 776000.00
HBIO balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 776000.00
HBIO income_statement (annual, 2023-12-31) — Normalized EBITDA: 8665000.00
HBIO income_statement (annual, 2023-12-31) — Normalized Income: -2915720.00
HBIO cash_flow (annual, 2023-12-31) — Operating Cash Flow: 14028000.00
HBIO cash_flow (annual, 2023-12-31) — Operating Gains Losses: 229000.00
HBIO income_statement (annual, 2023-12-31) — Operating Income: 1894000.00
HBIO income_statement (annual, 2023-12-31) — Operating Revenue: 112250000.00
HBIO balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 4339450.00
HBIO balance_sheet (annual, 2023-12-31) — Other Current Assets: 3940000.00
HBIO balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 5859000.00
HBIO balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 5276000.00
HBIO balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -14190000.00
HBIO income_statement (annual, 2023-12-31) — Other Gand A: 22757000.00
HBIO income_statement (annual, 2023-12-31) — Other Income Expense: -859000.00
HBIO balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 16036000.00
HBIO cash_flow (annual, 2023-12-31) — Other Non Cash Items: 280000.00
HBIO balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 6473000.00
HBIO balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 1476000.00
HBIO income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -227000.00
HBIO income_statement (annual, 2023-12-31) — Other Operating Expenses: 71000.00
HBIO balance_sheet (annual, 2023-12-31) — Other Properties: 4773000.00
HBIO balance_sheet (annual, 2023-12-31) — Payables: 5554000.00
HBIO balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 5554000.00
HBIO balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 3929000.00
HBIO balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
HBIO income_statement (annual, 2023-12-31) — Pretax Income: -2556000.00
HBIO cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 930000.00
HBIO balance_sheet (annual, 2023-12-31) — Properties: 0.00
HBIO cash_flow (annual, 2023-12-31) — Purchase Of PPE: -1788000.00
HBIO balance_sheet (annual, 2023-12-31) — Raw Materials: 15408000.00
HBIO balance_sheet (annual, 2023-12-31) — Receivables: 16099000.00
HBIO income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 44706000.00
HBIO income_statement (annual, 2023-12-31) — Reconciled Depreciation: 6998000.00
HBIO cash_flow (annual, 2023-12-31) — Repayment Of Debt: -15041000.00
HBIO income_statement (annual, 2023-12-31) — Research And Development: 11764000.00
HBIO balance_sheet (annual, 2023-12-31) — Retained Earnings: -145605000.00
HBIO cash_flow (annual, 2023-12-31) — Sale Of Business: 512000.00
HBIO cash_flow (annual, 2023-12-31) — Sale Of Investment: 0.00
HBIO income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 24060000.00
HBIO income_statement (annual, 2023-12-31) — Selling General And Administration: 46817000.00
HBIO balance_sheet (annual, 2023-12-31) — Share Issued: 4339450.00
HBIO income_statement (annual, 2023-12-31) — Special Income Charges: 0.00
HBIO cash_flow (annual, 2023-12-31) — Stock Based Compensation: 5000000.00
HBIO balance_sheet (annual, 2023-12-31) — Stockholders Equity: 73074000.00
HBIO balance_sheet (annual, 2023-12-31) — Tangible Book Value: -27000.00
HBIO income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -132720.00
HBIO income_statement (annual, 2023-12-31) — Tax Provision: 859000.00
HBIO income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.21
HBIO balance_sheet (annual, 2023-12-31) — Total Assets: 137366000.00
HBIO balance_sheet (annual, 2023-12-31) — Total Capitalization: 103778000.00
HBIO balance_sheet (annual, 2023-12-31) — Total Debt: 42773000.00
HBIO balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 73074000.00
HBIO income_statement (annual, 2023-12-31) — Total Expenses: 110356000.00
HBIO balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 64292000.00
HBIO balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 88328000.00
HBIO balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 37750000.00
HBIO income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 1894000.00
HBIO income_statement (annual, 2023-12-31) — Total Unusual Items: -632000.00
HBIO income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -632000.00
HBIO cash_flow (annual, 2023-12-31) — Unrealized Gain Loss On Investment Securities: 632000.00
HBIO balance_sheet (annual, 2023-12-31) — Work In Process: 4188000.00
HBIO balance_sheet (annual, 2023-12-31) — Working Capital: 22496000.00
HBIO balance_sheet (quarterly, 2024-09-30) — Current Debt: 3606000.00
HBIO balance_sheet (quarterly, 2024-09-30) — Current Provisions: 415000.00
HBIO cash_flow (quarterly, 2024-09-30) — Gain Loss On Sale Of Business: 0.00
HBIO cash_flow (quarterly, 2024-09-30) — Income Tax Paid Supplemental Data: 184000.00
HBIO balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 34252000.00
HBIO cash_flow (quarterly, 2024-09-30) — Long Term Debt Payments: -3550000.00
HBIO cash_flow (quarterly, 2024-09-30) — Net Business Purchase And Sale: 0.00
HBIO cash_flow (quarterly, 2024-09-30) — Net Long Term Debt Issuance: 5250000.00
HBIO balance_sheet (quarterly, 2024-09-30) — Other Current Borrowings: 3606000.00
HBIO cash_flow (quarterly, 2024-09-30) — Sale Of Business: 0.00
HBIO income_statement (annual, 2024-12-31) — +Operating Expense: 60977000.00
HBIO income_statement (annual, 2024-12-31) — +Total Revenue: 94135000.00
HBIO balance_sheet (annual, 2024-12-31) — Accounts Payable: 4787000.00
HBIO balance_sheet (annual, 2024-12-31) — Accounts Receivable: 14866000.00
HBIO balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -15820000.00
HBIO balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -15820000.00
HBIO balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 236579000.00
HBIO balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -215000.00
HBIO income_statement (annual, 2024-12-31) — Amortization: 5255000.00
HBIO cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 5430000.00
HBIO cash_flow (annual, 2024-12-31) — Amortization Of Intangibles: 5430000.00
HBIO income_statement (annual, 2024-12-31) — Amortization Of Intangibles Income Statement: 5255000.00
HBIO cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 0.00
HBIO income_statement (annual, 2024-12-31) — Basic Average Shares: 4353800.00
HBIO income_statement (annual, 2024-12-31) — Basic EPS: -2.80
HBIO cash_flow (annual, 2024-12-31) — Beginning Cash Position: 4283000.00
HBIO cash_flow (annual, 2024-12-31) — Capital Expenditure: -3263000.00
HBIO cash_flow (annual, 2024-12-31) — Capital Expenditure Reported: -619000.00
HBIO balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 7539000.00
HBIO balance_sheet (annual, 2024-12-31) — Capital Stock: 441000.00
HBIO balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 4108000.00
HBIO balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 4108000.00
HBIO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -131000.00
HBIO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -1344000.00
HBIO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 1440000.00
HBIO cash_flow (annual, 2024-12-31) — Change In Account Payable: -1785000.00
HBIO cash_flow (annual, 2024-12-31) — Change In Inventory: -64000.00
HBIO cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 1642000.00
HBIO cash_flow (annual, 2024-12-31) — Change In Other Working Capital: -702000.00
HBIO cash_flow (annual, 2024-12-31) — Change In Payable: -1785000.00
HBIO cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -1785000.00
HBIO cash_flow (annual, 2024-12-31) — Change In Receivables: 974000.00
HBIO cash_flow (annual, 2024-12-31) — Change In Working Capital: 65000.00
HBIO cash_flow (annual, 2024-12-31) — Changes In Account Receivables: 974000.00
HBIO cash_flow (annual, 2024-12-31) — Changes In Cash: -35000.00
HBIO balance_sheet (annual, 2024-12-31) — Common Stock: 441000.00
HBIO balance_sheet (annual, 2024-12-31) — Common Stock Equity: 63340000.00
HBIO income_statement (annual, 2024-12-31) — Cost Of Revenue: 39369000.00
HBIO balance_sheet (annual, 2024-12-31) — Current Assets: 45117000.00
HBIO balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 1158000.00
HBIO balance_sheet (annual, 2024-12-31) — Current Debt: 36956000.00
HBIO balance_sheet (quarterly, 2024-12-31) — Current Debt: 36956000.00
HBIO balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 38114000.00
HBIO balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 3806000.00
HBIO balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 3806000.00
HBIO balance_sheet (annual, 2024-12-31) — Current Liabilities: 54958000.00
HBIO cash_flow (annual, 2024-12-31) — Deferred Income Tax: 363000.00
HBIO cash_flow (annual, 2024-12-31) — Deferred Tax: 363000.00
HBIO cash_flow (annual, 2024-12-31) — Depreciation: 1727000.00
HBIO cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 7157000.00
HBIO income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 5255000.00
HBIO cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 7157000.00
HBIO income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 5255000.00
HBIO income_statement (annual, 2024-12-31) — Diluted Average Shares: 4353800.00
HBIO income_statement (annual, 2024-12-31) — Diluted EPS: -2.80
HBIO income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -12405000.00
HBIO income_statement (annual, 2024-12-31) — EBIT: -8129000.00
HBIO income_statement (annual, 2024-12-31) — EBITDA: -972000.00
HBIO cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -140000.00
HBIO cash_flow (annual, 2024-12-31) — End Cash Position: 4108000.00
HBIO cash_flow (annual, 2024-12-31) — Financing Cash Flow: -131000.00
HBIO balance_sheet (annual, 2024-12-31) — Finished Goods: 5222000.00
HBIO cash_flow (annual, 2024-12-31) — Free Cash Flow: -1823000.00
HBIO cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 1593000.00
HBIO cash_flow (quarterly, 2024-12-31) — Gain Loss On Investment Securities: 0.00
HBIO cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of Business: 0.00
HBIO cash_flow (quarterly, 2024-12-31) — Gain Loss On Sale Of Business: 0.00
HBIO income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -1593000.00
HBIO income_statement (quarterly, 2024-12-31) — Gain On Sale Of Security: 0.00
HBIO balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -15670000.00
HBIO income_statement (annual, 2024-12-31) — General And Administrative Expense: 21493000.00
HBIO balance_sheet (annual, 2024-12-31) — Goodwill: 56324000.00
HBIO balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 67456000.00
HBIO balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 15081000.00
HBIO balance_sheet (annual, 2024-12-31) — Gross PPE: 27058000.00
HBIO income_statement (annual, 2024-12-31) — Gross Profit: 54766000.00
HBIO income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 0.00
HBIO income_statement (annual, 2024-12-31) — Interest Expense: 3536000.00
HBIO income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 3536000.00
HBIO cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 3235000.00
HBIO balance_sheet (annual, 2024-12-31) — Inventory: 23245000.00
HBIO balance_sheet (annual, 2024-12-31) — Invested Capital: 100296000.00
HBIO cash_flow (annual, 2024-12-31) — Investing Cash Flow: -1344000.00
HBIO cash_flow (annual, 2024-12-31) — Issuance Of Debt: 8800000.00
HBIO cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: 0.00
HBIO balance_sheet (annual, 2024-12-31) — Leases: 2565000.00
HBIO balance_sheet (quarterly, 2024-12-31) — Leases: 2565000.00
HBIO balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 6381000.00
HBIO balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 6381000.00
HBIO cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 8800000.00
HBIO cash_flow (quarterly, 2024-12-31) — Long Term Debt Issuance: 0.00
HBIO cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -8573000.00
HBIO cash_flow (quarterly, 2024-12-31) — Long Term Debt Payments: -1000000.00
HBIO balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 18361000.00
HBIO balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 18361000.00
HBIO cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 0.00
HBIO cash_flow (quarterly, 2024-12-31) — Net Business Purchase And Sale: 0.00
HBIO balance_sheet (annual, 2024-12-31) — Net Debt: 32848000.00
HBIO income_statement (annual, 2024-12-31) — Net Income: -12405000.00
HBIO income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -12405000.00
HBIO income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -12405000.00
HBIO income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -12405000.00
HBIO income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -12405000.00
HBIO cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -12405000.00
HBIO income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -12405000.00
HBIO income_statement (annual, 2024-12-31) — Net Interest Income: -3536000.00
HBIO cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 1919000.00
HBIO cash_flow (quarterly, 2024-12-31) — Net Investment Purchase And Sale: 0.00
HBIO cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 227000.00
HBIO cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 227000.00
HBIO cash_flow (quarterly, 2024-12-31) — Net Long Term Debt Issuance: -1000000.00
HBIO income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -3536000.00
HBIO cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -738000.00
HBIO balance_sheet (annual, 2024-12-31) — Net PPE: 11238000.00
HBIO cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -2644000.00
HBIO balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -4116000.00
HBIO balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 710000.00
HBIO balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 710000.00
HBIO income_statement (annual, 2024-12-31) — Normalized EBITDA: 621000.00
HBIO income_statement (annual, 2024-12-31) — Normalized Income: -11146530.00
HBIO cash_flow (annual, 2024-12-31) — Operating Cash Flow: 1440000.00
HBIO cash_flow (annual, 2024-12-31) — Operating Gains Losses: 1593000.00
HBIO cash_flow (quarterly, 2024-12-31) — Operating Gains Losses: -1243000.00
HBIO income_statement (annual, 2024-12-31) — Operating Income: -6211000.00
HBIO income_statement (annual, 2024-12-31) — Operating Revenue: 94135000.00
HBIO balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 4407447.00
HBIO balance_sheet (annual, 2024-12-31) — Other Current Assets: 2898000.00
HBIO balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 36956000.00
HBIO balance_sheet (quarterly, 2024-12-31) — Other Current Borrowings: 36956000.00
HBIO balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 6537000.00
HBIO balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -15670000.00
HBIO income_statement (annual, 2024-12-31) — Other Gand A: 21493000.00
HBIO income_statement (annual, 2024-12-31) — Other Income Expense: -1918000.00
HBIO balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 11132000.00
HBIO cash_flow (annual, 2024-12-31) — Other Non Cash Items: 327000.00
HBIO balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 2833000.00
HBIO balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 1255000.00
HBIO income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -325000.00
HBIO income_statement (annual, 2024-12-31) — Other Operating Expenses: 1611000.00
HBIO balance_sheet (annual, 2024-12-31) — Other Properties: 6132000.00
HBIO balance_sheet (annual, 2024-12-31) — Payables: 4787000.00
HBIO balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 4787000.00
HBIO cash_flow (annual, 2024-12-31) — Pension And Employee Benefit Expense: 0.00
HBIO balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1714000.00
HBIO balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
HBIO income_statement (annual, 2024-12-31) — Pretax Income: -11665000.00
HBIO cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 380000.00
HBIO balance_sheet (annual, 2024-12-31) — Properties: 0.00
HBIO balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
HBIO cash_flow (annual, 2024-12-31) — Purchase Of PPE: -2644000.00
HBIO balance_sheet (annual, 2024-12-31) — Raw Materials: 15269000.00
HBIO balance_sheet (annual, 2024-12-31) — Receivables: 14866000.00
HBIO income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 37467000.00
HBIO income_statement (annual, 2024-12-31) — Reconciled Depreciation: 7157000.00
HBIO cash_flow (annual, 2024-12-31) — Repayment Of Debt: -8573000.00
HBIO income_statement (annual, 2024-12-31) — Research And Development: 10406000.00
HBIO balance_sheet (annual, 2024-12-31) — Retained Earnings: -158010000.00
HBIO cash_flow (annual, 2024-12-31) — Sale Of Business: 0.00
HBIO cash_flow (quarterly, 2024-12-31) — Sale Of Business: 0.00
HBIO cash_flow (annual, 2024-12-31) — Sale Of Investment: 1919000.00
HBIO cash_flow (quarterly, 2024-12-31) — Sale Of Investment: 0.00
HBIO income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 22212000.00
HBIO income_statement (annual, 2024-12-31) — Selling General And Administration: 43705000.00
HBIO balance_sheet (annual, 2024-12-31) — Share Issued: 4407447.00
HBIO income_statement (annual, 2024-12-31) — Special Income Charges: 0.00
HBIO cash_flow (annual, 2024-12-31) — Stock Based Compensation: 4340000.00
HBIO balance_sheet (annual, 2024-12-31) — Stockholders Equity: 63340000.00
HBIO balance_sheet (annual, 2024-12-31) — Tangible Book Value: -4116000.00
HBIO income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -334530.00
HBIO income_statement (annual, 2024-12-31) — Tax Provision: 740000.00
HBIO income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
HBIO balance_sheet (annual, 2024-12-31) — Total Assets: 126644000.00
HBIO balance_sheet (annual, 2024-12-31) — Total Capitalization: 63340000.00
HBIO balance_sheet (annual, 2024-12-31) — Total Debt: 44495000.00
HBIO balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 63340000.00
HBIO income_statement (annual, 2024-12-31) — Total Expenses: 100346000.00
HBIO balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 63304000.00
HBIO balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 81527000.00
HBIO balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 8346000.00
HBIO income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -6211000.00
HBIO income_statement (annual, 2024-12-31) — Total Unusual Items: -1593000.00
HBIO income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -1593000.00
HBIO balance_sheet (annual, 2024-12-31) — Work In Process: 2754000.00
HBIO balance_sheet (annual, 2024-12-31) — Working Capital: -9841000.00
HBIO income_statement (quarterly, 2025-03-31) — +Operating Expense: 13637000.00